• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

The differences of mechanisms between normal luteal formation and occurrence of ovarian hyperstimulation syndrome

Research Project

Project/Area Number 14571574
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionSapporo Medical University

Principal Investigator

ENDO Toshiaki  Sapporo Medical University, School of Medicine, Associate Professor, 医学部, 助教授 (90213595)

Co-Investigator(Kenkyū-buntansha) CHIBA Hideki  Sapporo Medical University, School of Medicine, Assistant Professor, 医学部, 講師 (00295346)
Project Period (FY) 2002 – 2003
Keywordscorous Luteum / ovarian hyperstimulation syndrome / vascular permeability / vascular endothelial growth factor / tight junction / claudin-5 / occludin
Research Abstract

Vascular endothelial growth factor(VEGF) is well known to stimulate both the growth of endothelium and vascular permeability. VEGF expression in the ovary is also reported to increase during normal luteal formation. In this study we investigated the mechanisms of the occurrence of ovarian hyperstimulation syndrome(OHSS).
The expression of VEGE and VEGF receptors(R) was extremely stimulated in the ovaries of OHSS rat models compared with corpora lutea of pseudopregnant rats. Vascular permeability examined with Evans blue was markedly increased in the ovaries of OHSS rats. Gonadotropin releasing hormone agonist(GnRHa) treatment blocked the increase of VEGF-VEGFR expression and vascular permeability of the ovaries of OHSS rats.
Tight junction proteins of endothelium are reported to play a pivotal role in vascular permeability. As there are known to be several sorts of tight junction proteins, we checked the expression of such proteins in the ovaries of OHSS rats.
Claudin-5 and occludin protein were significantly decreased in the ovaries OHSS rats. However, GnRHa treatment blocked the decrease in both proteins. Moreover, we clinically experienced that the continuation at GnRHa prevented the occurrence of OHSS during in vitro fertilization and embryo transfer.
In summary, the decreased expression of claudin-5 and occludin caused by excess expression of VEGF-VEGFR was speculated to change from normal luteal formation into the occurrence of OHSS.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Endo T., et al.: "Identical changes in Bax expression but not Fas Ligand expression, occur in structural luteolysis in gonadotropin releasing hormone agonist-and prolactin-treated superovulated rats."Life Sciences. (In press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Endo T., et al.: "Greater effectiveness of low molecular weight dextran (dextran 40) infusion for treatment of hemoconcentration due to severe ovarian hyperstimulation compared with human albumin infusion."Fertil Steril. (In press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitajima Y., et al.: "Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats."Fertil Steril. 81. 842-849 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Henmi H., et al.: "Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect."Fertil Steril. 80. 459-461 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Endo T., et al.: "Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos."Hum Reprod. 17. 2548-2551 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Endo T., Kiya T., Kitajima Y., Honnma H., Chida M., Hayashi T., Henmi H., Yamazaki K., Hayashi T., Manase K., Kudo R.: "Identical changes in Bax expression, but not Fas ligand expression, occur in structural luteolysis in gonadotropin releasing hormone agonist-and prolactin-treated superovulated rats"Life Science. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Endo T., Kitajima Y., Hayashi T., Fujii M., Hata H., Azumaguchi A.: "Greater effectiveness of low molecular weight dextran(dextran 40) infusion for treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome compared with human albumin infusion."Fertil Steril. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima Y, Endo T., Manase K., Nishikawa A., Shibuya M., Kudo R.: "Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor(VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats."Fertil Steril. 81. 842-849 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima Y, Endo T., Yamazaki K., Hayashi T., Kudo R.: "Successful twin pregnancy in panhypopituitarism caused by suprasellar germinoma."Obstet Gynecol. 102. 1205 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Henmi H., Endo T., Kitajima Y., Manase K., Hata H., Kudo R.: "Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect."Fertil Steril. 80. 459-461 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Endo T., Honnma H., Hayashi T., Chida M., Yamazaki K., Kitajima Y., Azumaguchi A., Kamiya H., Kudo R.: "Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos."Hum Reprod. 17. 2548-2551 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Manase K., Endo T., Henmi H., Kitajima Y., Yamazaki K., Nishikawa A., Mitaka T., Sato H., Kudo R.: "The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea."Mol Hum Reprod. 8. 742-749 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi